Multiple banks are competing to join a $4.25 billion debt financing backing Curium’s acquisition of radiopharmaceutical company Lantheus Holdings Inc., before the deal is syndicated to investors next year.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.